TAKEDA PHARMACEUTICALS U.S.A., INC. V. MYLAN PHARMACEUTICALS INC.
Before Prost, Newman, and Hughes. Appeal from the United States District Court for the District of Delaware -
Summary: The scope of a contract term may...more
8/7/2020
/ Appeals ,
Contract Interpretation ,
Dismissal With Prejudice ,
Generic Drugs ,
IP License ,
Irreparable Harm ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Preliminary Injunctions
EAGLE PHARMACEUTICALS INC. V. SLAYBACK PHARMA LLC.
Before O’Malley, Reyna, and Chen. Appeal from the United States District Court for the District of Delaware.
Summary: The disclosure-dedication doctrine precludes...more
Traditionally, it has been fairly uncommon to see new legislation in intellectual property (IP) law, compared to other areas of law. Instead, courts have generally been the avenue through which changes in IP law have been...more